Product Information
CEFTRIAXONE 250 MG VIAL is a generic product labeled by Apotex Corp., priced at $1.2533 per EA under NDC 60505615104. Its NADAC has been published 174 times since Feb 19, 2020.
Strength
250 mg/1
Manufacturer
Apotex Corp.NDC
60505615104
Classification
Generic
Dosage Form
INJECTION, POWDER, FOR SOLUTION
Route
INTRAMUSCULAR; INTRAVENOUS
Last Updated
2/19/2025
Active Ingredients
CEFTRIAXONE SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA203702On Market Since
6/30/2017
Pharmacological Classes
Price Statistics
The NADAC for CEFTRIAXONE 250 MG VIAL has been published 174 times since Feb 19, 2020, and over the history we have for it it has declined 26.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.2533 per EA |
|---|---|
| All-time high | $1.7420 (Oct 14, 2020) |
| All-time low | $0.9480 (Jul 17, 2024) |
| 52-week high | $1.2533 |
| 52-week low | $1.2533 |
| Median price | $1.5037 |
| Average price | $1.4356 |
| Largest weekly change | -42.3% (Jul 17, 2024) |
| Weeks tracked | 174 |
| Tracking since | Feb 19, 2020 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 31% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CEFTRIAXONE 250 MG VIAL?
The current National Average Drug Acquisition Cost (NADAC) for CEFTRIAXONE 250 MG VIAL, manufactured by Apotex Corp., is $1.2533 per EA (NDC 60505615104), effective Feb 11, 2026.
How has the price of CEFTRIAXONE 250 MG VIAL changed over time?
Over the history we have for it, the NADAC for CEFTRIAXONE 250 MG VIAL has declined 26.2%. It has been tracked across 174 weekly CMS publications since Feb 19, 2020.
What are the highest and lowest recorded NADAC prices for CEFTRIAXONE 250 MG VIAL?
Since Feb 19, 2020, the NADAC for CEFTRIAXONE 250 MG VIAL has ranged from a low of $0.9480 (Jul 17, 2024) to a high of $1.7420 (Oct 14, 2020), with a median of $1.5037 per EA.
Are there cheaper alternatives to CEFTRIAXONE 250 MG VIAL?
Yes. 3 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, CEFTRIAXONE 250 MG VIAL, is $0.8622 per EA — about 31% below CEFTRIAXONE 250 MG VIAL.
Who manufactures CEFTRIAXONE 250 MG VIAL?
CEFTRIAXONE 250 MG VIAL (NDC 60505615104) is labeled by Apotex Corp., and CMS classifies it as a generic product.
Related Drugs
Same classification